The cell and gene therapy sector has never lacked attention, but all too often, the narrative swings from one extreme to ...

Paras Biopharma extensive efforts have resulted in successful scale-up, optimization & development of a biologically-active onco-immunology, “peptide FC-fusion ...

A profound transformation is taking place in therapeutic discovery, development, and delivery.2026 will be a pivotal year for ...

MONTREAL--(Marketwire - Oct 9, 2012) - Sunshine Biopharma Inc. (OTCBB: SBFM), a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various ...

Before the advent of biologics, commercialization of a therapeutic relied on successfully scaling up to meet market demand. This scaling-up strategy expanded biomanufacturing capacity by upsizing the ...

LyoWave CEO Drew Strongrich (left), principal engineer Steven Pugia (right) and firmware developer Shiv Kothari (center) conduct research in the company’s development facility in the Purdue Research ...